Emmett Cunningham

Emmett Cunningham

Director/Miembro de la Junta en GALERA THERAPEUTICS, INC. .

Fortuna: - $ al 30/04/2024

63 años
Health Technology
Consumer Services
Finance

Perfil

Emmett T.
Cunningham
is the founder of Ophthalmology Innovation Summit (founded in 2009) and Placid0, Inc. (founded in 2020).
Dr. Cunningham is also the founder of Pr3vent, Inc..
Dr. Cunningham's current job(s) include Director at SARcode Bioscience, Inc., Independent Director at Galera Therapeutics, Inc., Director-Uveitis Service at California Pacific Medical Center, Senior Managing Director at Blackstone, Inc., Director at SFJ Pharmaceuticals, Inc., Director at Lumos Pharma Sub, Inc., Director at Viewpoint Therapeutics, Inc., Director at Silk Technologies Ltd., Adjunct Professor at Stanford University School of Medicine, Research Associate at UCSF School of Medicine, and Research Associate at Francis I Proctor Foundation.
Dr. Cunningham's former job(s) include Director at NewLink Genetics Corp., Independent Director at Restoration Robotics, Inc. (2011-2018), Director at Annexon, Inc. (2014-2021), Director at Graybug Vision, Inc. (2016-2020), Director at The University of California, San Francisco (1995-2001), Managing Director & Partner at Clarus Ventures LLC (2006-2018), Senior Managing Director at Blackstone Life Sciences Advisors LLC, Independent Director at Lumos Pharma, Inc. (2016-2021), Principal at Pfizer Inc., Senior Vice President-Medical Strategy at Oldtech, Inc. (2001-2005), and Professor at New York University (2002-2005).
Dr. Cunningham's education history includes an undergraduate degree from Drexel University, graduate and doctorate degrees from The Johns Hopkins University, and a doctorate degree from the University of California San Diego.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
14/06/2023 0 ( -.--% ) - $ 30/04/2024

Cargos activos de Emmett Cunningham

EmpresasCargoInicio
GALERA THERAPEUTICS, INC. Director/Miembro de la Junta 01/09/2018
BLACKSTONE INC. Inversor de Capital Privado -
Director/Miembro de la Junta -
Stanford University School of Medicine Corporate Officer/Principal 01/07/2008
UCSF School of Medicine Corporate Officer/Principal -
Francis I Proctor Foundation Corporate Officer/Principal -
Corporate Officer/Principal -
Director/Miembro de la Junta -
Director/Miembro de la Junta -
░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ -
Todos los cargos activos de Emmett Cunningham

Antiguos cargos conocidos de Emmett Cunningham.

EmpresasCargoFin
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░░
Ver el detalle de la experiencia de Emmett Cunningham.

Formación de Emmett Cunningham.

Drexel University Undergraduate Degree
The Johns Hopkins University Doctorate Degree
University of California San Diego Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Emmett Cunningham.

Relaciones

100 +

Relaciones de 1er grado

28

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas5
PFIZER, INC.

Health Technology

ANNEXON, INC.

Health Technology

GALERA THERAPEUTICS, INC.

Health Technology

BLACKSTONE INC.

Finance

LUMOS PHARMA, INC.

Health Technology

Empresas privadas16

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Finance

Health Technology

Health Services

Health Technology

Health Technology

Finance

Health Services

Finance

Francis I Proctor Foundation

Technology Services

Ver las conexiones de la empresa
  1. Bolsa de valores
  2. Insiders
  3. Emmett Cunningham
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA